🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hamlet BioPharma AB (publ) (XSAT:HAMLET.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.08
+0.10 (1.67%)
At close: Sep 30, 2026

Hamlet BioPharma AB Statistics

Total Valuation

XSAT:HAMLET.B has a market cap or net worth of SEK 1.13 billion. The enterprise value is 1.13 billion.

Market Cap1.13B
Enterprise Value 1.13B

Important Dates

The next confirmed earnings date is Thursday, February 11, 2027.

Earnings Date Feb 11, 2027
Ex-Dividend Date n/a

Share Statistics

XSAT:HAMLET.B has 186.18 million shares outstanding.

Current Share Class 146.27M
Shares Outstanding 186.18M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 25.95%
Owned by Institutions (%) 8.47%
Float 97.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 697,031.23
PB Ratio 33.51
P/TBV Ratio 71.78
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.19, with zero debt.

Current Ratio 4.19
Quick Ratio 4.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3,648.55

Financial Efficiency

Return on equity (ROE) is -125.17% and return on invested capital (ROIC) is -78.61%.

Return on Equity (ROE) -125.17%
Return on Assets (ROA) -70.82%
Return on Invested Capital (ROIC) -78.61%
Return on Capital Employed (ROCE) -163.50%
Weighted Average Cost of Capital (WACC) 6.15%
Revenue Per Employee 271
Profits Per Employee -9.16M
Employee Count6
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +12.38% in the last 52 weeks. The beta is 0.35, so XSAT:HAMLET.B's price volatility has been lower than the market average.

Beta (5Y) 0.35
52-Week Price Change +12.38%
50-Day Moving Average 6.27
200-Day Moving Average 6.65
Relative Strength Index (RSI) 54.86
Average Volume (20 Days) 164,242

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, XSAT:HAMLET.B had revenue of SEK 1,624 and -54.96 million in losses.

Revenue 1,624
Gross Profit 1,624
Operating Income -55.23M
Pretax Income -54.96M
Net Income -54.96M
EBITDA -44.69M
EBIT -55.23M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 16.41 million in cash and no debt, with a net cash position of 16.41 million or 0.09 per share.

Cash & Cash Equivalents 16.41M
Total Debt n/a
Net Cash 16.41M
Net Cash Per Share 0.09
Equity (Book Value) 33.78M
Book Value Per Share n/a
Working Capital 15.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -46.49 million and capital expenditures -353,000, giving a free cash flow of -46.84 million.

Operating Cash Flow -46.49M
Capital Expenditures -353,000
Depreciation & Amortization 10.54M
Net Borrowing n/a
Free Cash Flow -46.84M
FCF Per Share -0.25
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -3,400,971.31%
Pretax Margin -3,384,540.46%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XSAT:HAMLET.B does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -4.86%
FCF Yield -4.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on March 15, 2021. It was a forward split with a ratio of 3.

Last Split Date Mar 15, 2021
Split Type Forward
Split Ratio 3

Scores

Altman Z-Score n/a
Piotroski F-Score 1